Navigation Links
Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
Date:7/25/2012

PALM BEACH, Fla., July 25, 2012 /PRNewswire-USNewswire/ -- The Genetics Policy Institute (GPI) announced that it has joined with the Oakland University William Beaumont Institute for Stem Cell and Regenerative Medicine (ISCRM) as an organizing partner of the Second Midwest Conference on Stem Cell Biology and Therapy October 5-7, 2012 in Rochester, Michigan.

"GPI is proud to partner with ISCRM in this important scientific conference, which will showcase the latest discoveries from top laboratories around the region and beyond. We take pride that ISCRM was officially launched at our 2010 World Stem Cell Summit in Detroit. GPI's support for this conference underscores our continuing commitment to advance stem cell research in the Midwest," said Bernard Siegel, GPI's Executive Director and founder of the annual World Stem Cell Summit.

Researchers from hospitals, medical organizations, academic institutions and the business community throughout the country will discuss not only the latest advances in this rapidly expanding field of medical science, but the ethical and moral issues that surround it.

"There are unlimited opportunities in the rapidly progressing areas of stem cell biology and regenerative medicine," said Dr. Rasul Chaudhry, director of the ISCRM. "This conference is a great way to showcase not only Oakland University, Beaumont Health System, and ISCRM but the strength of academics and research in Michigan as a whole. 

The conference is open to the public, and physicians, nurses, physical therapists, occupational therapists and others in health care professions may be able to earn continuing medical education credits by attending. 

Early registration, which runs through Wednesday, Aug. 15, is $300 for the public and $150 for students, residents and post-doctoral students. Registration after Aug. 15 is $350 and $175 respectively. Optional workshops are $100. Sponsorship opportunities are still available.

For more information on the Second Midwest Conference on Stem Cell Biology and Therapy, visit the website at www.oakland.edu/scbt.

About Genetics Policy Institute (GPI): GPI is a 501c3 nonprofit foundation with the mission to promote and defend stem cell research and its application in medicine to develop therapeutics and cures for many otherwise intractable diseases and disorders. GPI pursues this mission through production of its flagship annual World Stem Cell Summit, publication of the World Stem Cell Report, the Stem Cell Action Awards, special projects, speaking engagements, teaching initiatives and strategic collaborations.

About the World Stem Cell Summit: The global stem cell community will converge December 3-5, 2012 at the 8th World Stem Cell Summit ,held  at the Palm beach County Convention Center in West Palm Beach, Florida USA, to chart the future of regenerative medicine. By sharing knowledge and advancing collaborations, the Summit is an engine for discovery, funding and commercialization. Planned by and for the stem cell and regenerative medicine community, the Summit brings global stakeholders together to solve global challenges. The goal of the Summit is to accelerate the discovery and development of lifesaving cures and therapies. The Summit builds a foundation to advance cell therapies by establishing a supportive environment of regulation, legislation, financing, reimbursement and patient advocacy. For more information about the World Stem cell Summit, please visit www.worldstemcellsummit.com.


'/>"/>
SOURCE Genetics Policy Institute
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Interleukin Genetics Reports Third Quarter 2011 Financial Results
2. Metamark Genetics Signs Collaboration Agreement on Novel Therapeutic Targets with Janssen Biotech
3. Ambry Genetics Launches Illumina MiSeq Next-Gen Sequencing Services
4. Cytogenetics - Technologies, Markets and Companies
5. deCODE Genetics, in Collaboration with Academic Colleagues, Discovers Three Variants in the Sequence of the Human Genome that Affect the Risk of Thyroid Cancer
6. GeneThera, Inc. Acquires Applied Genetics, S.A.
7. Genetics Policy Institute (GPI) Files Additional Legal Arguments in Sherley v. Sebelius Stem Cell Case
8. Good Start Genetics Announces $14M Series B Financing, Expands Senior Management Team
9. Khan Academy and 23andMe Partner to Promote Genetics Education on DNA Day
10. JS Genetics announces launch of XCAT-KS, a bloodless, cheek swab test for the diagnosis of Klinefelter syndrome and other Male sex chromosome aneuploidies
11. Roche 454 Life Sciences and SoftGenetics Sign Co-Promotion Agreement for Next-Gen Sequencing Software Tools
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... -- Research and Markets has announced the addition of ... Application - Global Opportunity Analysis and Industry Forecast, 2014-2022" report ... ... projected to reach $15,737 million by 2022 from $6,521 in 2015, ... Omic technologies segment accounted for more than half of ...
(Date:1/19/2017)... and HOUSTON , Jan. ... Prenatal") today announced the formation of its Medical/Clinical ... clinicians and industry veterans who enhance the range ... it accelerates development of its novel prenatal diagnostic ... medical, clinical and strategic guidance for the company,s ...
(Date:1/19/2017)... Research and Markets ... has announced the addition of the ... 2025" report to their offering. Report ... provides a detailed analysis on current and future market trends to identify ... market values as the base numbers Key market trends ...
(Date:1/19/2017)... ... 19, 2017 , ... November Research Group, LLC, a global ... device manufacturers and regulators, is proud to announce the worldwide release of PRIMO ... to provide product vigilance departments with the flexibility and ease of use of ...
Breaking Biology Technology:
(Date:1/6/2017)... , Jan. 6, 2017  Privately-held CalciMedica, Inc., ... in healthy volunteers of a novel calcium release-activated ... acute pancreatitis. Acute pancreatitis, sudden ... mild disorder, but can be very serious.  In severe ... sepsis, where extended hospital stays, time in the ...
(Date:1/3/2017)... Jan. 3, 2017 Onitor, provider of digital ... Onitor Track, an innovative biometric data-driven program designed to ... month at the 2017 Consumer Electronics Show (CES) in ... In the U.S., the World Health Organization (WHO), have ... of adults who are overweight or obese. WHO also ...
(Date:12/19/2016)... , España y TORONTO , 19 de diciembre ... Northern Biologics Inc. que permitirá el desarrollo acelerado de MSC-1, un ... en varios tipos de tumor en 2017, con múltiples sitios previstos ... ... clase con objetivo en el factor inhibidor de leucemia (LIF), una ...
Breaking Biology News(10 mins):